| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8dad13e34a819e3e9f39aba5fc721594 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate |
2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_422ee5b01c725603cec703ea2befcc65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ed7ab4cd9b9533e74af606a2bd243c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43409f42ad6cd5148672e55143354838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c347e0a50d7fd8787cbb3b585fccab3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d80f6a38e607d33f93753bdb9b0a5935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38741cf5019d4bbcb0d5ecebcc695410
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea386e3b76de1e502ef00abedb949ed5 |
| publicationDate |
2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10561717-B2 |
| titleOfInvention |
Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer |
| abstract |
Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer. |
| priorityDate |
2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |